Get the Stockscreener App
14.02
1.67%
0.23
After Hours:
14.02
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $14.02, with a volume of 644.12K.
It is up +1.67% in the last 24 hours and up +6.62% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$13.79
Open:
$13.8
24h Volume:
644.12K
Relative Volume:
1.49
Market Cap:
$614.49M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-25.04
EPS:
-0.56
Net Cash Flow:
$-20.63M
1W Performance:
+0.36%
1M Performance:
+6.62%
6M Performance:
+73.73%
1Y Performance:
+180.40%
1-Day Range:
$13.74
$14.20
1-Week Range:
$13.58
$14.48
52-Week Range:
$3.45
$15.08
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Perceptive Advisors LLC Lowers Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 17.7% in September - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Sees Large Drop in Short Interest - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Wall Street SWOT: AxoGen stock shows promise amid leadership change and strong Q2 - Investing.com
Rhumbline Advisers Increases Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen (NASDAQ:AXGN) Stock Rating Upgraded by StockNews.com - MarketBeat
AxoGen (NASDAQ:AXGN) Upgraded by StockNews.com to Buy - Defense World
First Light Asset Management LLC Purchases 2,578,147 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
First September Gains in 5 Years? Buy 3 Breakout Stocks Now - Benzinga
Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen - Yahoo Finance
First Light Asset Management LLC Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Acadian Asset Management LLC Makes New Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Bank of New York Mellon Corp Buys 13,798 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Divisadero Street Capital Management LP Purchases 587,024 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Stock Holdings Lifted by Divisadero Street Capital Management LP - Defense World
Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year? - Yahoo Finance
AxoGen (NASDAQ:AXGN) Upgraded to “Buy” at StockNews.com - Defense World
AxoGen (NASDAQ:AXGN) Hits New 1-Year High at $15.08 - MarketBeat
AxoGen (NASDAQ:AXGN) Hits New 12-Month High at $15.08 - Defense World
Short Interest in AxoGen, Inc. (NASDAQ:AXGN) Increases By 10.0% - Defense World
AXGN (Axogen Inc.) may reap gains as insiders became active recently - Knox Daily
AxoGen: An Intriguing Growth Story (NASDAQ:AXGN) - Seeking Alpha
AxoGen (NASDAQ:AXGN) & Heyu Biological Technology (OTCMKTS:HYBT) Financial Comparison - Defense World
AxoGen (NASDAQ:AXGN) Upgraded by StockNews.com to Buy - MarketBeat
Here's Why You Should Add Inogen Stock to Your Portfolio Now - Benzinga
North America Peripheral Nerve Repair Devices Market By Application - Third Eye News
Axogen stock soars to 52-week high, hits $13.79 By Investing.com - Investing.com Australia
Even With A 28% Surge, Cautious Investors Are Not Rewarding AxoGen, Inc.'s (NASDAQ:AXGN) Performance Completely - Simply Wall St
Axogen stock soars to 52-week high, hits $13.79 - Investing.com
Axogen stock soars to 52-week high, hits $13.79 By Investing.com - Investing.com UK
Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance? - Benzinga
AXGN Stock Sees Surge of Approximately 1.68% in Last Five Days - Knox Daily
Owens & Minor Stock to Gain From New Collaboration With Google Cloud - Benzinga
AxoGen (NASDAQ:AXGN) Hits New 1-Year High at $13.52 - MarketBeat
Rice Hall James & Associates LLC Purchases 41,095 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc - Yahoo Finance
United States Peripheral Nerve Repair Market By Application - Third Eye News
AxoGen (NASDAQ:AXGN) Lowered to Hold at StockNews.com - Defense World
AxoGen (NASDAQ:AXGN) Rating Lowered to Hold at StockNews.com - MarketBeat
Nerve Repair and Regeneration Market 2024 Growing Opportunity and Competitive landscape – Abbott Laboratories, Axogen Corporation, Baxter, Boston Scientific Corporation – Cauverynews - Cauverynews
AxoGen (NASDAQ:AXGN) Hits New 1-Year High at $13.35 - Defense World
AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft® - TipRanks
Axogen completes FDA submission for nerve graft product By Investing.com - Investing.com Australia
Axogen stock soars to 52-week high, reaches $13.33 - Investing.com India
AxoGen (NASDAQ:AXGN) Sets New 52-Week High at $13.35 - MarketBeat
Axogen stock soars to 52-week high, reaches $13.33 By Investing.com - Investing.com Canada
Axogen completes FDA submission for nerve graft product By Investing.com - Investing.com Canada
Axogen stock soars to 52-week high, reaches $13.33 - Investing.com
Axogen stock soars to 52-week high, reaches $13.33 By Investing.com - Investing.com UK
Axogen completes FDA submission for nerve graft product - Investing.com
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):